WHO WE ARE
Zymetas is a medical diagnostic company that designs and develops in vitro diagnostic tests for the PCR based detection and differentiation of pathogens such as viruses, bacteria or parasites. Zymetas provides its synthetic biology and PCR based solutions to CDC, APHIS and clinical laboratories all over the world.
WHAT WE DO
Molecular diagnostic tests from Zymetas are based on real-time PCR technology and are packaged as ready-to-use kits. Zymetas product catalogue contains over 200 kits that are compatible with open real-time PCR platforms and automated workflow platforms.